These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 26468399)

  • 1. Evaluation of AUSDRISK as a screening tool for lifestyle modification programs: international implications for policy and cost-effectiveness.
    Malo JA; Versace VL; Janus ED; Laatikainen T; Peltonen M; Vartiainen E; Coates MJ; Dunbar JA
    BMJ Open Diabetes Res Care; 2015; 3(1):e000125. PubMed ID: 26468399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characteristics of men classified at high-risk for type 2 diabetes mellitus using the AUSDRISK screening tool.
    Aguiar EJ; Morgan PJ; Collins CE; Plotnikoff RC; Callister R
    Diabetes Res Clin Pract; 2015 Apr; 108(1):45-54. PubMed ID: 25707921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of two methods for assessing diabetes risk in a pharmacy setting in Australia.
    Kilkenny MF; Johnson R; Andrew NE; Purvis T; Hicks A; Colagiuri S; Cadilhac DA
    BMC Public Health; 2014 Nov; 14():1227. PubMed ID: 25427845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cut-off points of fasting fingertip capillary blood glucose for detecting both undiagnosed diabetes and pre-diabetes].
    Zhang YL; Guo SQ; Ma WB; Wang J; Bai GQ; Yang Q; Ti SF; Ma R; Wei RP; Liu WX; Li Z; Yang L; Liu DW; Li ZH
    Zhonghua Liu Xing Bing Xue Za Zhi; 2010 Oct; 31(10):1174-8. PubMed ID: 21162825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence and predictors of undiagnosed type 2 diabetes and pre-diabetes among adult Egyptians: a community-based survey.
    Farag HFM; Elrewany E; Abdel-Aziz BF; Sultan EA
    BMC Public Health; 2023 May; 23(1):949. PubMed ID: 37231362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Arabic version of the Australian type 2 diabetes risk assessment tool (AUSDRISK): translation and validation.
    Farag HFM; Sultan EA; Elrewany E; Abdel-Aziz BF
    BMC Res Notes; 2022 Sep; 15(1):303. PubMed ID: 36138452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimal cut-off points of fasting plasma glucose for two-step strategy in estimating prevalence and screening undiagnosed diabetes and pre-diabetes in Harbin, China.
    Bao C; Zhang D; Sun B; Lan L; Cui W; Xu G; Sui C; Wang Y; Zhao Y; Wang J; Li H
    PLoS One; 2015; 10(3):e0119510. PubMed ID: 25785585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The likelihood of diabetes based on the proposed definitions for impaired fasting glucose.
    Gao W; Dong Y; Nan H; Tuomilehto J; Qiao Q
    Diabetes Res Clin Pract; 2008 Jan; 79(1):151-5. PubMed ID: 17825938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AUSDRISK: an Australian Type 2 Diabetes Risk Assessment Tool based on demographic, lifestyle and simple anthropometric measures.
    Chen L; Magliano DJ; Balkau B; Colagiuri S; Zimmet PZ; Tonkin AM; Mitchell P; Phillips PJ; Shaw JE
    Med J Aust; 2010 Feb; 192(4):197-202. PubMed ID: 20170456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The clinical utility of the AUSDRISK tool in assessing change in type 2 diabetes risk in overweight/obese volunteers undertaking a healthy lifestyle intervention.
    Martin A; Neale EP; Tapsell LC
    Prev Med Rep; 2019 Mar; 13():80-84. PubMed ID: 30534513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Impact of lowering the cut-point for impaired fasting glucose on the distribution of impaired glucose regulation subcategories in Chinese adult population].
    Yang ZJ; Yang WY; Xiao JZ; Li GW; Wang Y
    Zhonghua Yi Xue Za Zhi; 2004 Nov; 84(21):1773-6. PubMed ID: 15631770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Using the AUSDRISK score to screen for pre-diabetes and diabetes in GP practices: a case-finding approach.
    Fleming K; Weaver N; Peel R; Hure A; McEvoy M; Holliday E; Parsons M; Acharya S; Luu J; Wiggers J; Rissel C; Ranasinghe P; Jayawardena R; Samman S; Attia J
    Aust N Z J Public Health; 2022 Apr; 46(2):203-207. PubMed ID: 34762354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Congruence between the Indian Diabetes Risk Score and Australian Type 2 Diabetes Risk Assessment tool screening in Asian-Indians.
    Fernandez RS; Frost S
    Nurse Res; 2013 Nov; 21(2):36-9. PubMed ID: 24171636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can a screening programme for diabetes be applied to another population?
    Glümer C; Borch-Johnsen K; Colagiuri S
    Diabet Med; 2005 Sep; 22(9):1234-8. PubMed ID: 16108854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fasting cut-offs in determining the prevalence of diabetes and intermediate glucose abnormality in a non-obese population.
    Sayeed MA; Mahtab H; Khanam PA; Keramat Ali SM; Chowdhury RI; Vaaler S; Hussain A; Azad Khan AK
    Bangladesh Med Res Counc Bull; 2004 Dec; 30(3):105-14. PubMed ID: 16240981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AUSDRISK - application in general practice.
    Wong KC; Brown AM; Li SC
    Aust Fam Physician; 2011 Jul; 40(7):524-6. PubMed ID: 21743862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening for impaired glucose tolerance in obese children and adolescents: a validation and implementation study.
    Morandi A; Maschio M; Marigliano M; Miraglia Del Giudice E; Moro B; Peverelli P; Maffeis C
    Pediatr Obes; 2014 Feb; 9(1):17-25. PubMed ID: 23296488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin resistance, beta cell function and cardiovascular risk factors in Ghanaians with varying degrees of glucose tolerance.
    Amoah AG; Schuster DP; Gaillard T; Osei K
    Ethn Dis; 2002; 12(4):S3-10-7. PubMed ID: 12477148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Performance of Stepwise Screening Methods in Identifying Individuals at High Risk of Type 2 Diabetes in an Iranian Population.
    Lotfaliany M; Hadaegh F; Mansournia MA; Azizi F; Oldenburg B; Khalili D
    Int J Health Policy Manag; 2022 Aug; 11(8):1391-1400. PubMed ID: 34060272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Feasibility of the FINDRISC questionnaire to identify individuals with impaired glucose tolerance in Swedish primary care. A cross-sectional population-based study.
    Hellgren MI; Petzold M; Björkelund C; Wedel H; Jansson PA; Lindblad U
    Diabet Med; 2012 Dec; 29(12):1501-5. PubMed ID: 22443428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.